The utility of pharmacogenetic testing to support the treatment of bipolar disorder

Marta Ielmini,1 Nicola Poloni,1 Ivano Caselli,1 Jordi Espadaler,2 Miquel Tuson,2 Alessandro Grecchi,3 Camilla Callegari1 1Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy; 2AB-BIOTICS S.A, R&D Unit, Sant Cugat del Valles, Barcelona, Spain; 3AS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ielmini M, Poloni N, Caselli I, Espadaler J, Tuson M, Grecchi A, Callegari C
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018-03-01
Col·lecció:Pharmacogenomics and Personalized Medicine
Matèries:
Pharmacogenetics testing
bipolar disorder
personalized medicine
pharmacogenetics
adverse events
Accés en línia:https://www.dovepress.com/the-utility-of-pharmacogenetic-testing-to-support-the-treatment-of-bip-peer-reviewed-article-PGPM
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars